In order to assess the chloride channel gene CLCN2 as a candidate susceptibility gene for childhood absence epilepsy, parametric and non-parametric linkage analysis was performed in 65 nuclear pedigrees. This provided suggestive evidence for linkage with heterogeneity: NPL score = 2.3, p<0.009; HLOD = 1.5, α = 0.44. Mutational analysis of the entire genomic sequence of CLCN2 was performed in 24 unrelated patients from pedigrees consistent with linkage, identifying 45 sequence variants including the known non-synonymous polymorphism rs2228292 (G2154C, Glu718Asp) and a novel variant IVS4+12G>A. Intra-familial association analysis using the pedigrees and a further 308 parent-child trios showed suggestive evidence for transmission disequilibrium of the G2154C minor allele: AVE-PDT 
0.44. Mutational analysis of the entire genomic sequence of CLCN2 was performed in 24 unrelated patients from pedigrees consistent with linkage, identifying 45 sequence variants including the known non-synonymous polymorphism rs2228292 (G2154C, Glu718Asp) and a novel variant IVS4+12G>A. Intra-familial association analysis using the pedigrees and a further 308 parent-child trios showed suggestive evidence for transmission disequilibrium of the G2154C minor allele: AVE-PDT 
2
(1) = 5.17, p<0.03. Case-control analysis provided evidence for a protective effect of the IVS4+12G>A minor allele: 
(1) = 7.27, p<0.008. The 65 nuclear pedigrees were screened for three previously identified mutations shown to segregate with a variety of idiopathic generalised epilepsy phenotypes (597insG, IVS2-14del11, and G2144A) but none were found. We conclude that CLCN2 may be a susceptibility locus in a subset of cases of childhood absence epilepsy.
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Introduction
The absence epilepsies are a group of idiopathic generalised epilepsies (IGEs) including childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), epilepsy with myoclonic absences and eyelid myoclonus with absences (Engel, Jr., Everett 5 2001) . The main features of CAE are frequent absence seizures (10-40 per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Age of onset peaks at 6-7 years. Generalized tonic-clonic seizures (GTCS) often develop during adolescence. Otherwise, absence seizures may either remit or persist into adulthood.
In contrast, JAE manifests around puberty with absence seizures and GTCS (1989) .
There is evidence to suggest that CAE and JAE share a similar genetic architecture allowing them to be assessed as a single phenotype in genetic studies (Berkovic et al., 1987; Marini et al., 2004) .
Genome-wide linkage analysis of IGE-multiplex families has demonstrated evidence for susceptibility loci on chromosomes 3q26, 14q23 and 2q36 (Sander et al., 2000) . Mutations in the chloride channel gene CLCN2 (chromosome 3q27-q28) have been identified in three of 46 unrelated IGE families demonstrating linkage to 3q26 (Haug et al., 2003) . These mutations result in a premature stop codon (M200fsX231), an altered splice site (del74-117) and a single amino-acid substitution (Gly715Glu).
Two different mutations (Arg688Gly and Glu718Asp) and an intronic variant (IVS17-3C>T) have been shown to cosegregate with epilepsy in two families with idiopathic epilepsy (D'Agostino et al., 2004) .
CLCN2 encodes an 898-residue transmembrane protein ClC-2 which is widely expressed in the brain and other tissues (Thiemann et al., 1992) . ClC-2 has been shown to be involved in the control of GABAergic synaptic transmission (Sik et al., 2000) thus providing a plausible biological basis for how loss of CLCN2 function could affect neuronal excitability.
Available evidence thus suggests that mutations in CLCN2 may underlie a proportion of IGE phenotypes potentially including CAE and JAE. The aim of this work was to test this hypothesis by linkage analysis using microsatellite loci spanning Everett 6 CLCN2 in 65 nuclear families each with a proband with CAE and at least one other member affected by CAE or JAE, and to perform direct re-sequencing of the entire genomic sequence in 24 affected unrelated individuals from pedigrees consistent with linkage to determine the presence of any potentially disease-associated variants. The disease-associated mutations previously identified by Haug et al. were also screened for in our resource because some of their cases with the mutations had either CAE or JAE.
Materials and methods
Subjects
A resource of 65 nuclear pedigrees each with a proband with CAE and at least one other member affected by CAE or JAE (including 145 cases) and 308 independent parent-child trios with CAE was ascertained. They were all of Caucasian origin from European populations including the UK, France, Germany, Austria, the Netherlands, Denmark, Sweden, Finland, Italy and Greece, and from the USA and Canada. Affected individuals were classified using diagnostic criteria based on the ILAE classification of CAE and JAE (Engel, Jr., 2001 Genomic DNA was extracted from whole blood or cheek swab samples according to standard protocols.
Control samples were obtained from the European Collection of Cell Cultures
(ECACC) human random control panels 1, 2 and 3 (HRC-1, HRC-2 and HRC-3; 94 samples per plate). The ECACC HRC panels include DNA from blood donors who are all UK Caucasians and are characterised by gender and age at venesection. All donors have given written informed consent for their blood to be used for research purposes. Different numbers of controls were used at different stages of the analysis simply due to availability of these samples to us (Table 1 summarises in which samples each variant was genotyped). Due to variation in quality between assays, the number of successful genotypes varies between SNPs in both cases and controls, thus these final numbers will be quoted in the text. Conformation to Hardy-Weinberg Equilibrium (HWE) was verified in all SNPs typed in controls.
Linkage Analysis
Everett 8 Linkage analysis was performed using two fluorescently-labelled microsatellite markers, D3S3609 and D3S3583, which flank CLCN2. They span a physical distance of 250kb (NCBI sequence map) over a predicted genetic distance of 1.14cM. Only the 65 pedigrees were used for linkage analysis.
Genotyping was performed on the ABI 373 Sequence Analyser using the Genescan® and Genotyper® software. All pedigrees were checked for Mendelian inheritance using the PedCheck program (O'Connell and Weeks, 1998) . Any pedigrees which failed this test were re-genotyped. Formal linkage analysis was performed using GeneHunter 2.1 (Kruglyak et al., 1996) . Only those individuals with CAE or JAE were considered affected. Parametric analysis was performed under the assumption of autosomal dominant inheritance with a penetrance of 50%. These parameters correspond to the available data on Mendelian segregation in this trait.
They are conservative and the low penetrance reduces the risk of false negative results. A disease allele frequency of 0.01 and a phenocopy rate of 0.0001 were assumed. A disease allele frequency of 1% allows the variant to be classifiable as a polymorphism which would fit the common disease/common variant hypothesis. A phenocopy rate of 0.0001 allows for the assumed heterogeneous architecture of CAE.
The heterogeneity LOD score (HLOD) and an estimate of , which represents the proportion of pedigrees consistent with linkage at a specific locus, were calculated.
The nonparametric linkage (NPL) statistic (Sall), along with the corresponding degree of significance, was also calculated by GeneHunter. The Sall statistic assesses the degree of allele-sharing in all affected individuals and is valuable as it is a "modelfree" form of analysis thus bypassing inherent problems of a parametric analysis such as misspecification of parameters.
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Screening for Known Variants
Primers were designed in-house for IVS2-14del11 (details available on request) and this mutation was screened for in the 65 nuclear pedigrees using the same methodology as for the microsatellite markers. The other two mutations identified by Haug et al. (597insG and G2144A) were screened for in the pedigrees by KBiosciences (http://www.kbioscience.co.uk) using the Amplifluor™ chemistry for genotyping. One further known non-synonymous variant rs9820367 (G2003C, Thr668Ser) was screened for by KBiosciences in our entire resource and in 94 DNA samples from HRC-1.
CLCN2 Sequencing in 24 Families with Evidence for Linkage
Bi-directional direct re-sequencing of~15kb of genomic DNA (chromosome 3, 185561969-185547096; accession number GI 51511463) including all 24 coding exons,~1kb of predicted promoter and~1kb of the 3' region was performed.
Twenty-four unrelated cases were chosen from families consistent with linkage to the CLCN2 locus. This re-sequencing work was performed by Polymorphic DNA Technologies Inc., using standard Sanger dideoxy sequencing protocols (http://www.polymorphicdna.com). Any putative functional variants were then genotyped in the ECACC plates to determine a population minor allele frequency (MAF) and in the entire resource.
Intrafamilial association analysis was performed using the pedigree disequilibrium test (PDT) (Martin et al., 2000; Martin et al., 2001 ). The PDT produces 
Results
Linkage Analysis
Multipoint analysis gave a maximum HLOD of 1.5 (α=0.44) at microsatellite marker D3S3609. The NPL statistic at this position was also at its maximum of 2.3 (p<0.009) (Figure 1 ).
Screening for Known Variants
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None of the three mutations reported by 597insG or G2144A) were detected in our resource of 65 pedigrees. The G allele of the nonsynonymous SNP rs9820367 (G2003C, Thr668Ser) was detected with a frequency of 43.9% amongst 329 unrelated affecteds. The comparative minor allele frequency (MAF) was 47.6% in 84 ECACC controls (in HWE). See Table 1 for full details of MAFs in the different populations. Case-control analysis demonstrated that this difference was not significant and intra-familial association analysis was also not significant (data not shown).
CLCN2 Sequencing in 24 Families with Evidence for Linkage
Re-sequencing identified 45 variants including: 39 novel variants and 6 known polymorphisms; one known missense polymorphism; 3 synonymous variants; one 5' UTR and one 3' UTR variant; and 39 intronic SNPs (Figure 2 ). All cases had at least 3 polymorphisms, with the highest number being 14 (Figure 3 ). There did not seem to be any discernible pattern to the possession of these variants. Table 1 provides MAF details of those variants which were consequentially typed in a larger resource based on the available data regarding expected MAF and on the results from the bioinformatics analyses. 
Screening for rs2228292
The known missense polymorphism identified through re-sequencing was rs2228292 (G2154C, Glu718Asp). The MAF amongst our 24 sequenced cases was 4.8%. ESEfinder predicted that this SNP would fall within a binding motif for the SF2/ASF protein and that the change from a G to a C would lower the matrix score 
Screening for IVS4+12G>A
A novel variant, IVS4+12G>A, was identified with a MAF of 12.9% amongst our unrelated 24 cases. Due to its proximity to the exon-intron boundary this was deemed potentially functional. 
Discussion
ClC channels are members of a large family of Cl − selective ion channels found in a diverse array of organisms. They allow the flow of Cl − ions across the cell membrane down the electrochemical gradient. The 3D structure of human ClC channels has not been directly characterised but has been inferred from Escherichia coli ClC (EcClC) structure. They are composed of two identical subunits each with its own independent pore for Cl − ions and 3 ion-binding sites: S int ; S cen ; and S ext .
These 3 sites are formed by 4 conserved sequences of amino acid residues (Dutzler et al., 2002) . When open, all 3 binding sites are occupied by Cl − ions, whilst the S ext site is blocked by the side chain of a glutamate residue when closed (Dutzler et al., 2003) .
There are 9 isoforms in humans involved in an array of physiological functions (Jentsch et al., 2002) . ClC-2 has been shown to be involved in the control of GABAergic synaptic transmission (Sik et al., 2000) and is expressed in various epithelia and in the brain (Thiemann et al., 1992) . The CLCN2 gene was located to chromosome 3q26-qter (Cid et al., 1995) and has been shown to be mutated in a small subset of families with IGE (Haug et al., 2003; Sander et al., 2000) . The work presented here used 65 nuclear pedigrees for linkage analysis using two microsatellite markers spanning the gene. The maximum HLOD score was 1.5 with an α of 0.44, which is suggestive of linkage in the case of a complex disease, which is expected to Everett 14 be polygenic and heterogeneous. Thus no single locus would be expected to produce a high maximum HLOD score in this resource. Furthermore the non-parametric analysis produces a maximum NPL score of 2.3 which is statistically significant (p<0.009) at the same position, providing further confirmatory supporting evidence for linkage to this locus. However, mutation screening did not detect the mutations reported to co-segregate with IGE by Haug et al. (2003) . The previously identified missense polymorphism rs9820367 (Thr668Ser) was detected with similarly high MAF in both our unrelated affecteds and the ECACC controls at a little under 50%.
Unsurprisingly, there was no statistically significant evidence for disease association with this variant.
Direct re-sequencing in affecteds from pedigrees consistent with linkage identified a further 45 variants. This is a frequency of approximately one every 300 nucleotides which is similar to the predicted frequency of a polymorphism (Kruglyak and Nickerson, 2001) . Four of these variants were genotyped in controls and across our resources, either because the MAF in the 24 cases was markedly different from that quoted on dbSNP, or because of a putative functional effect. Of these four, two demonstrated some statistical support for disease association. The first was a known missense SNP rs2228292 (G2154C, Glu718Asp). Although the MAF amongst our 24 cases differed from that among the control ECACC samples (4.8% vs 3.3%), casecontrol analysis using more than 300 unrelated affecteds from our whole resource was not significant. However, the PDT does provide evidence for transmission disequilibrium with overtransmission of the minor allele. This difference in result may reflect an underlying population stratification which might affect the case-control analysis but not the PDT. This polymorphism was also detected in a previous study in one Polish family in which the proband and his father had familial frontal lobe Everett 15 epilepsy (FFLE) (D'Agostino et al., 2004) . The minor allele was found to segregate with the disease and was not found in any control samples. Although this is a partial rather than a generalised epilepsy such as CAE, it is possible that rs2228292 has an effect on general seizure susceptibility rather than on predisposition to a specific epilepsy. The residue which is altered by this variant (Glu718Asp) is situated close to the Gly715Glu polymorphism identified by Haug et al. (2003) . They predict that this change will subtly alter voltage-dependent gating, which may cause membrane depolarization and hyperexcitability. However, functional analysis of this polymorphism has not provided consistent support for this postulate (Niemeyer et al., 2004 ). An alternative suggestion is that the Gly715Glu variant severely affects the ability of ATP to bind to the CBS domains, which is thought necessary for ClC channels to open (Scott et al., 2004; Vanoye and George, Jr., 2002) . The same hypothesis could thus be proposed for the Glu718Asp polymorphism. Although the change from a glutamate to an aspartate is a conservative change with a Grantham score of 45 (Grantham, 1974) , it has been predicted that 75% of conservative nonsynonymous changes will have a functional effect (Zhang, 2000) . All mammalian homologues of CLCN2 contain a glutamate residue at the position corresponding to human Glu718, providing further support for the suggestion that any alteration at this site could have a functional effect. Finally, the substitution of the G with a C is predicted to affect a potential ESE, causing it to have a weaker effect, as well as creating an ESE that does not exist in the wild type. Both these factors could affect splicing providing an alternative way in which this variant may affect the protein.
The second variant which demonstrated statistical disease association was IVS4+12G>A, which has also been detected in families with idiopathic epilepsy (D'Agostino et al., 2004) . We found no evidence for preferential transmission of This study has provided further support for a potential role for CLCN2 in IGE, specifically CAE. Of the variants identified, the most likely to have a putative functional role would be rs2228292 (Glu718Asp), for a number of reasons: it is a missense polymorphism; there is significant evidence for transmission disequilibrium; the comparative residue is conserved across species; it has previously been found to segregate with the disease in another family with idiopathic epilepsy; it alters an amino-acid located 3 residues along from another epilepsy-associated variant, Gly715Glu, which is predicted to have a functional effect via either altering gating properties or changing the ATP-binding ability of the CBS domains. Lastly, bioinformatics analysis predicts that splicing may be affected via the disruption and creation of ESE motifs. Clearly, functional studies will be necessary to demonstrate if these predictions are true. 
